论文部分内容阅读
中药是中华民族的传统瑰宝,中国人民的骄傲,在国人心中具有崇高的地位。但中药在国际市场中的状况却一直不容乐观。有资料表明,全球中药市场营业额中,日本占80％,韩国占10％,而中国只占到5％。在中国有“中药之王”美称的人参,同等重量的售价仅为韩国产高丽参的1/10,价格相差何等悬殊！如今,中国已加入了WTO,中药在国际市场上将面临更严峻的
Chinese medicine is a traditional gem of the Chinese nation. The pride of the Chinese people has a high status in the hearts of the Chinese people. However, the situation of Chinese medicine in the international market has not been optimistic. Data show that the global Chinese medicine market turnover, Japan accounted for 80% of South Korea accounted for 10%, while China accounted for only 5%. In China, there is “ginseng king” reputation of ginseng, the same weight of the price is only Korea ginseng 1/10, the price difference between the disparity! Now that China has joined the WTO, Chinese medicine will face even tougher challenges in the international market